Clinical trials
Completed Observational Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 11 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 6 |
| 2018 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 113 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 25 |
| National Heart, Lung, and Blood Institute (NHLBI) | 17 |
| Organon and Co | 9 |
| Gachon University Gil Medical Center | 3 |
| JW Pharmaceutical | 3 |
| Novartis Pharmaceuticals | 3 |
| University of Washington | 3 |
| Amgen | 2 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2 |
| Elpen Pharmaceutical Co. Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 113 |
| Cardiovascular Diseases | 25 |
| Heart Diseases | 18 |
| Hypertension | 18 |
| Coronary Disease | 14 |
| Dyslipidemias | 14 |
| Atherosclerosis | 13 |
| Diabetes Mellitus | 12 |
| Hyperlipidemias | 7 |
| Hyperlipoproteinemia Type II | 5 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.